DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

Lexicon Pharmaceuticals Announces Poster Presentation at the ASCO 2020 Gastrointestinal Cancers Symposium

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) announced today that data from a poster highlighting XERMELO® (telotristat ethyl) will be presented at the American Society for Clinical Oncology (ASCO) 2020 Symposium (January 23-25, San Francisco, CA). Poster Pres

Benzinga · 01/20/2020 23:01

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) announced today that data from a poster highlighting XERMELO® (telotristat ethyl) will be presented at the American Society for Clinical Oncology (ASCO) 2020 Symposium (January 23-25, San Francisco, CA).

Poster Presentation (all times local)

Friday, January 24, 12:00 pm-1:30 pm, 4:30 pm-5:30 pm

Morse, M. et al. Exploring telotristat ethyl's antiproliferative effects in patients with carcinoid syndrome (TELEACE): A real-world observational study (Abstract #618; Poster Board: F21)